Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Dec 18, 2019

Pfizer and Mylan Announce Two Future Viatris Board Members

Dec 02, 2019

Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.

Nov 25, 2019

Mylan to Present at the Evercore ISI HealthCONx Conference

Nov 20, 2019

Mylan Announcement of Redemption of Certain Notes Due 2020

Nov 12, 2019

Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination

Nov 05, 2019

Mylan Reports Third Quarter 2019 Results and Updates 2019 Guidance

Oct 25, 2019

Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance

Oct 24, 2019

Mylan to Release Third Quarter 2019 Financial Results on Nov. 5, 2019

Oct 21, 2019

Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting

Sep 27, 2019

Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2022 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.